The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Bruun, R. D.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Bruun, R. D.

Am J Psychiatry 1988; 145:621-624
Copyright © 1988 by American Psychiatric Association


REGULAR ARTICLES

Subtle and underrecognized side effects of neuroleptic treatment in children with Tourette's disorder

RD Bruun
Department of Psychiatry, Cornell University Medical School, New York.

A variety of side effects developed in children treated with neuroleptics for Tourette's disorder. Of 208 children, 34 manifested dose-related symptoms of dysphoria, nine experienced a worsening of symptoms of Tourette's disorder that was attributed to akathisia, five became hostile and aggressive, three developed "fog states" that disappeared with discontinuation of neuroleptics or treatment with primidone, and three experienced symptoms of tardive dyskinesia that resolved with time. This data base of neuroleptic-treated children with Tourette's disorder demonstrates a variety of subtle and underrecognized side effects that may not be as readily discernible in children receiving neuroleptics for a primary psychiatric disorder.


This article has been cited by other articles:


Home page
Clinical Child Psychology and PsychiatryHome page
K. Becker, M. Holtmann, M. El-Faddagh, and M. H. Schmidt
Separation Anxiety Triggered by Atypical Neuroleptic Medication in an Adolescent with Tourette's Syndrome
Clinical Child Psychology and Psychiatry, October 1, 2004; 9(4): 597 - 603.
[Abstract] [PDF]


Home page
NeurologyHome page
L. Scahill, J.F. Leckman, R.T. Schultz, L. Katsovich, and B.S. Peterson
A placebo-controlled trial of risperidone in Tourette syndrome
Neurology, April 8, 2003; 60(7): 1130 - 1135.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
H. S. Singer, J. Wendlandt, M. Krieger, and J. Giuliano
Baclofen treatment in Tourette syndrome: A double-blind, placebo-controlled, crossover trial
Neurology, March 13, 2001; 56(5): 599 - 604.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. L. Gilbert, G. Sethuraman, L. Sine, S. Peters, and F. R. Sallee
Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial
Neurology, March 28, 2000; 54(6): 1310 - 1315.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. M. Robertson
Tourette syndrome, associated conditions and the complexities of treatment
Brain, March 1, 2000; 123(3): 425 - 462.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
Short-term versus longer term pimozide therapy in Tourette's syndrome: A preliminary study
Neurology, March 1, 1999; 52(4): 874 - 874.
[Abstract] [Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 1988 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org